Bcl-2 inhibitor and apigenin worked synergistically in human malignant neuroblastoma cell lines and increased apoptosis with activation of extrinsic and intrinsic pathways. [electronic resource]
Producer: 20091001Description: 705-10 p. digitalISSN:- 1090-2104
- Antineoplastic Protocols
- Apigenin -- therapeutic use
- Apoptosis -- drug effects
- Benzopyrans -- therapeutic use
- Cell Line, Tumor
- Cell Survival -- drug effects
- Dose-Response Relationship, Drug
- Drug Synergism
- ErbB Receptors -- antagonists & inhibitors
- Humans
- Neuroblastoma -- drug therapy
- Nitriles -- therapeutic use
- Proto-Oncogene Proteins c-bcl-2 -- antagonists & inhibitors
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.